Data / Drug companies / Symed Labs Limited
Symed Labs Limited: 37 products in the FDA NDC directory, labeler code 66022
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Symed Labs Limited (labeler code 66022) lists 37 products in the FDA National Drug Code Directory. By type: 37 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on January 1, 2026.
The request: Watch Symed Labs Limited (FDA labeler code 66022): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66022
- Products in commercial distribution
- 37
- Packages
- 39
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 3, Schedule IV 4
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- January 1, 1982
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 37 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 37 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 37 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Flibanserin | 66022-0123 | Powder | Bulk ingredients | January 1, 2026 |
| Otilonium bromide | 66022-0305 | Powder | Bulk ingredients | June 28, 2024 |
| Bilastine (form-i) | 66022-0213 | Powder | Bulk ingredients | June 28, 2024 |
| Ezetimibe | 66022-0212 | Powder | Bulk ingredients | December 13, 2023 |
| Modafinil | 66022-0208 | Powder | Bulk ingredients | October 14, 2023 |
| Vortioxetine hydrobromide | 66022-0211 | Powder | Bulk ingredients | September 30, 2023 |
| Bilastine (form-ii) | 66022-0210 | Powder | Bulk ingredients | September 30, 2023 |
| Hydroxychloroquine sulfate | 66022-0209 | Powder | Bulk ingredients | September 30, 2023 |
| Hydroxyzine pamoate | 66022-0122 | Powder | Bulk ingredients | June 23, 2023 |
| Sertraline hydrochloride | 66022-0304 | Powder | Bulk ingredients | October 4, 2021 |
| Prucalopride succinate | 66022-0207 | Powder | Bulk ingredients | December 14, 2018 |
| Deferasirox | 66022-0301 | Powder | Bulk ingredients | May 18, 2017 |
| Sucroferric oxyhydroxide | 66022-0302 | Powder | Bulk ingredients | November 27, 2013 |
| Brimonidine tartrate | 66022-0110 | Powder | Bulk ingredients | August 23, 2013 |
| Carbinoxamine maleate | 66022-0121 | Powder | Bulk ingredients | March 28, 2013 |
| Rivaroxaban | 66022-0203 | Powder | Bulk ingredients | July 1, 2011 |
| Dronedarone hydrochloride | 66022-0118 | Powder | Bulk ingredients | July 1, 2009 |
| Iloperidone | 66022-0115 | Powder | Bulk ingredients | May 6, 2009 |
| Meprobamate | 66022-0105 | Powder | Bulk ingredients | February 27, 2008 |
| Levocetirizine dihydrochloride | 66022-0108 | Powder | Bulk ingredients | January 28, 2008 |
| Levocetirizine dihydrochloride | 66022-0108 | Powder | Bulk ingredients | January 28, 2008 |
| Iron sucrose | 66022-0119 | Powder | Bulk ingredients | March 20, 2005 |
| Eszopiclone | 66022-0106 | Powder | Bulk ingredients | December 15, 2004 |
| Lanthanum carbonate | 66022-0116 | Powder | Bulk ingredients | October 16, 2004 |
| Linezolid | 66022-0201 | Powder | Bulk ingredients | April 18, 2000 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.